HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.
6th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 28-30 | London, UK
Tissue Chip for Drug Screening
Tissue Chip for Drug Screening
- Bio-Chips
- Microelectronics
- Microfabrication and Microfluidics
Tissue chips are engineered microsystems that represent units of human organs like the lung, liver and heart modeling both structure and performance. The chips merge techniques from the pc industry with modern tissue engineering to mix miniature models of living organ tissues on a transparent microchip. It is to develop bioengineered devices to enhance the method of predicting whether drugs are going to be safe or toxic in humans.
During human clinical trials, approximately 90 percent of candidate drugs fail because they are unsafe (~30% ) or ineffective (~60 %). Even when pre-clinical cell and animal studies seem promising, problems occur because drugs tested with these models often don't have an equivalent response in humans.
Committee Members
Nagy Habib
Imperial College London, United Kingdom
Lucie Bacakova
Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Marco Polettini
DVM, ItalySubmit your abstract Today
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy